ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years
Sung‐Hoon Kim
Matched on ORCID iD 0000-0002-1570-3230; OpenAlex author ID A5100429324. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper
Papers 5
- Designing a tumor landscape-modifying vaccine with a unique TLR2/6 agonist for refractory pancreatic cancer. Last author DOI 10.1038/s41423-026-01480-1↗
- Prediction of Prognosis in Pancreatic Cancer According to Methionyl-tRNA Synthetase 1 Expression as Determined by Immunohistochemical Staining. Co-author DOI 10.3390/cancers15225413↗
- Inhibition of MUC1 biosynthesis via threonyl-tRNA synthetase suppresses pancreatic cancer cell migration. Last author DOI 10.1038/emm.2017.231↗
- HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Co-author DOI 10.1038/onc.2012.193↗
- Sensitization of human pancreatic cancer cells harboring mutated K-ras to apoptosis. First author DOI 10.1371/journal.pone.0040435↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Dong Ki Lee · 2 shared papers, 2018–2023 · strength 0.25
- Seongmin Cho · 1 shared paper, 2026 · strength 0.22
- Joon Seong Park · 1 shared paper, 2023 · strength 0.17
- Jae Hee Cho · 1 shared paper, 2023 · strength 0.17
- Sung Ill Jang · 1 shared paper, 2023 · strength 0.17
- Seung Jae Jeong · 1 shared paper, 2018 · strength 0.08
- Ling Shen · 1 shared paper, 2012 · strength 0.05
- Chang Yan Chen · 1 shared paper, 2012 · strength 0.05
- Kyounghyun Kim · 1 shared paper, 2013 · strength 0.04
- Stephen H Safe · 1 shared paper, 2013 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.